Indeed, the suggestion of possible cardiovascular benefit seen in the safety studies is now being formally examined in large randomized-controlled trials with primary cardiovascular end points
However, persistent redness, warmth, or swelling lasting more than 24 hours, signs of infection (pustules, increasing pain, fever), or allergic reactions (hives, difficulty breathing) require immediate medical attention and are NOT typical semaglutide side effects
The First Triple G-Agonist In their Nature Medicine editorial this week A Revolution in Obesity Treatment, Lingvay and Agarwal highlighted the results of the first triple incretin-like drugretatrutidewith completed Phase 2 randomized trials
Core semaglutide patents are scheduled to expire across several emerging markets, enabling generic and biosimilar entry, while extended patent protections in the United States (U.S.), European Union (EU), United Kingdom (UK) and Japan are expected to maintain branded exclusivity into the early 2030s
Lee TY, Kuo S, Yang CY, Ou HT
Apoptosis 30:19892007 Qin Y, Shi G-P (2011) Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases